HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roxane Desjardins Selected Research

Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)

7/2020Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors.
1/2019Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug.
12/2018Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue.
1/2018Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.
12/2017PACE4 Undergoes an Oncogenic Alternative Splicing Switch in Cancer.
8/2017Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations.
8/2017PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression.
1/2017Rational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3.
2/2015PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.
1/2015Multi-Leu PACE4 Inhibitor Retention within Cells Is PACE4 Dependent and a Prerequisite for Antiproliferative Activity.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roxane Desjardins Research Topics

Disease

16Prostatic Neoplasms (Prostate Cancer)
07/2020 - 11/2012
11Neoplasms (Cancer)
07/2020 - 11/2012
3Anthrax
06/2010 - 07/2007
3Influenza in Birds (Avian Flu)
06/2010 - 07/2007
2Human Influenza (Influenza)
01/2014 - 07/2007
2Infections
01/2014 - 07/2007
1Adenocarcinoma
08/2017
1Breast Neoplasms (Breast Cancer)
08/2017
1Hepatocellular Carcinoma (Hepatoma)
11/2016
1Ascites
05/2014
1Ovarian Neoplasms (Ovarian Cancer)
05/2014
1Neoplasm Metastasis (Metastasis)
05/2014
1Septic Shock (Toxic Shock Syndrome)
04/2012
1Cytokine Release Syndrome
04/2012
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
10/2009
1Hyperlipoproteinemia Type III (Broad Beta Disease)
10/2009
1Carcinoma (Carcinomatosis)
01/2009
1Communicable Diseases (Infectious Diseases)
07/2008
1Acute Disease
07/2007
1Hyperinsulinism (Hyperinsulinemia)
03/2007

Drug/Important Bio-Agent (IBA)

15Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
07/2020 - 07/2007
9FurinIBA
12/2018 - 07/2007
7Peptides (Polypeptides)IBA
01/2019 - 07/2007
3EnzymesIBA
07/2020 - 02/2015
3Proteins (Proteins, Gene)FDA Link
05/2014 - 07/2008
3Hemagglutinins (Hemagglutinin)IBA
01/2014 - 07/2007
2Protein Isoforms (Isoforms)IBA
07/2020 - 12/2017
2Serine Proteases (Serine Protease)IBA
01/2018 - 01/2017
2AndrogensIBA
12/2017 - 11/2012
2LDL Receptors (LDL Receptor)IBA
11/2016 - 10/2009
2PeptidomimeticsIBA
02/2015 - 01/2014
2Small Interfering RNA (siRNA)IBA
05/2014 - 01/2014
1E2F Transcription FactorsIBA
07/2020
1Prostate-Specific Antigen (Semenogelase)IBA
01/2019
1ProdrugsIBA
01/2019
1AlbuminsIBA
01/2019
1Serine (L-Serine)FDA Link
12/2018
1Enzyme Precursors (Zymogens)IBA
12/2017
1Biomarkers (Surrogate Marker)IBA
08/2017
13-Mercaptopropionic Acid (3 Mercaptopropionic Acid)IBA
08/2017
1Estrogen ReceptorsIBA
08/2017
1Proprotein Convertase 9IBA
11/2016
1GlypicansIBA
11/2016
1peptide AIBA
01/2015
1Antineoplastic Agents (Antineoplastics)IBA
05/2014
1tetrapeptide carbamateIBA
05/2014
1AcidsIBA
01/2014
1Shiga Toxin (Shigella Toxin)IBA
01/2014
1Tetrazolium SaltsIBA
01/2014
1Messenger RNA (mRNA)IBA
01/2014
1Catalytic RNA (Ribozymes)IBA
01/2014
1ErbB Receptors (EGF Receptor)IBA
11/2012
1LipopolysaccharidesIBA
04/2012
1CytokinesIBA
04/2012
1LDL Lipoproteins (beta Lipoproteins)IBA
10/2009
1LDL CholesterolIBA
10/2009
1LigandsIBA
10/2009
1Epidermal Growth Factor (EGF)IBA
10/2009
1ApolipoproteinsIBA
10/2009
1N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA
10/2009
1Pharmaceutical PreparationsIBA
07/2008
1ExotoxinsIBA
07/2007
1anthrax toxin (anthrax lethal factor)IBA
07/2007
1Glucose (Dextrose)FDA LinkGeneric
03/2007
1Blood Glucose (Blood Sugar)IBA
03/2007
1Insulin (Novolin)FDA Link
03/2007

Therapy/Procedure

2Therapeutics
01/2014 - 07/2007